Most not long ago, it has been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to some wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts as being a scavenger and does